185 related articles for article (PubMed ID: 22975604)
21. Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
Chin RI; Rao YJ; Hwang MY; Spencer CR; Pierro M; DeWees T; Patel P; Sinha P; Gay HA; Daly M; Haughey BH; Nussenbaum B; Adkins DR; Lewis JS; Thorstad WL
Cancer; 2017 Dec; 123(23):4594-4607. PubMed ID: 28881377
[TBL] [Abstract][Full Text] [Related]
22. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
Eisbruch A; Harris J; Garden AS; Chao CK; Straube W; Harari PM; Sanguineti G; Jones CU; Bosch WR; Ang KK
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1333-8. PubMed ID: 19540060
[TBL] [Abstract][Full Text] [Related]
23. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
24. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
25. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
[TBL] [Abstract][Full Text] [Related]
26. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
28. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.
Kerr P; Myers CL; Butler J; Alessa M; Lambert P; Cooke AL
J Otolaryngol Head Neck Surg; 2015 May; 44(1):17. PubMed ID: 25964113
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of definitive intensity-modulated radiation therapy for oropharyngeal cancer: retrospective analysis of treatment efficacy and safety.
Kimura K; Kodaira T; Tomita N; Tachibana H; Makita C; Yoshida M; Nishikawa D; Hirakawa H; Suzuki H; Hanai N; Hasegawa Y
Jpn J Clin Oncol; 2016 Jan; 46(1):78-85. PubMed ID: 26496935
[TBL] [Abstract][Full Text] [Related]
30. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
Shueng PW; Wu LJ; Chen SY; Hsiao CH; Tien HJ; Cheng PW; Kuo YS; Chen YJ; Chen CA; Hsieh PY; Hsieh CH
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):715-21. PubMed ID: 19879069
[TBL] [Abstract][Full Text] [Related]
31. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.
Garden AS; Morrison WH; Wong PF; Tung SS; Rosenthal DI; Dong L; Mason B; Perkins GH; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):438-44. PubMed ID: 17141972
[TBL] [Abstract][Full Text] [Related]
32. Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.
Caula A; Boukhris M; Guerlain J; Tao Y; Breuskin I; Mirghani H; Temam S; Gorphe P
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1161-1166. PubMed ID: 30666440
[TBL] [Abstract][Full Text] [Related]
33. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.
Claus F; Duthoy W; Boterberg T; De Gersem W; Huys J; Vermeersch H; De Neve W
Oral Oncol; 2002 Sep; 38(6):597-604. PubMed ID: 12167438
[TBL] [Abstract][Full Text] [Related]
34. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
[TBL] [Abstract][Full Text] [Related]
35. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
36. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.
Been MJ; Watkins J; Manz RM; Gentry LR; Leverson GE; Harari PM; Hartig GK
Laryngoscope; 2008 Aug; 118(8):1377-82. PubMed ID: 18418275
[TBL] [Abstract][Full Text] [Related]
37. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
[TBL] [Abstract][Full Text] [Related]
38. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
Janssen S; Glanzmann C; Huber G; Studer G
Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
[TBL] [Abstract][Full Text] [Related]
39. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
Clavel S; Nguyen DH; Fortin B; Després P; Khaouam N; Donath D; Soulières D; Guertin L; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):582-9. PubMed ID: 21277695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
